1989165438+10, the first product of Rong Sheng, "hepatitis b surface detection kit", came out.
1June, 990, Rong Sheng passed the rectification and acceptance of the first batch of diagnostic reagent enterprises of the Ministry of Health, and obtained the pharmaceutical production license.
In May, 1994, Rong Sheng introduced a replacement "trust" card kit.
June 1995 "Shanghai Rong Sheng Biotechnology Co., Ltd." established in accordance with the new Company Law was formally established at No.99 Fahua Road, Shanghai, with its capital and shares increased to 26 million yuan.
1In July, 1995, Rong Sheng introduced "Know Now”EIA method to detect HBV" two and a half "and anti -HCV enzyme-linked immunosorbent assay kit.
In June, 1996, Rong Sheng was recognized by Shanghai Science and Technology Commission and became the first batch of "Shanghai High-tech Enterprises".
1May, 1998, the patent of "comb dot immunoassay kit" was approved with the patent number of ZL97 2 342 16.8.
1998 10, the anniversary of the founding of Rong Sheng 10, the scale has grown to: the factory building is 2,500m2 (including 500m2 in purification workshop), the capital is 36 million yuan, the employees are 7 1 person, and there are more than 40 kinds of products, with the output value of that year exceeding 60 million yuan.
In June, 2000, Rong Sheng cooperated with the United States to launch the special biochemical reagent (airborne reagent) for BIORESUN series automatic biochemical analyzer.
200 1 10, Rong Sheng successfully passed the ISO9002 quality system certification of the company by NSF International Consulting and Certification Organization of the United States, and obtained the export license.
065438+2002 10, the whole factory in Rong Sheng successfully passed the "Good Manufacturing Practices (GMP)" certification of the US Food and Drug Administration in China, setting a new milestone in Rongsheng.
In August 2002, Rong Sheng International's fourth generation "semi-automatic, universal automatic biochemical instrument liquid single reagent" was newly launched.
From June 5438 to February 2002, Rong Sheng formally established the "Rong Sheng Technology Center" and hired Chinese-American scientists as the directors of the company's CSO and technology center, making R&D personnel account for 20% of the company's total employees.
In March, 2003, Rong Sheng founded Rong Sheng Super, a quarterly magazine, to look at the whole industry from the perspective of an enterprise and lead an industry with its unique style.
In June 2003, Rong Sheng ISO9002 quality management system was successfully upgraded to ISO900 1:2000 version.
From June 5th to February, 2003, Rong Sheng successfully held the first "Rong Sheng Cup" China Laboratory Medicine Knowledge Competition in collaboration with the National Health Industry Enterprise Management Association, China Medical Laboratory Branch, Clinical Laboratory Center of the Ministry of Health and Health News.
In March, 2004, the first "2.5" hepatitis B kit was listed in China.
In May 2004, HIV( 1+2) produced in Rong Sheng successfully passed GMP (Good Manufacturing Practices) certification, and the company obtained the second GMP certification.
In July 2004, as the first major achievement since the establishment of the company's technology center, the potassium sodium enzyme kit was successfully developed and officially put into production. AFU, GPDA, 5'- nucleotide and adenosine deaminase kits were successfully developed.
In June 2004, 5438+ 10 was awarded the 2003 Contract Credit Enterprise Certificate issued by Shanghai Administration for Industry and Commerce and the 2003 Contract Credit Grade AAA Certificate issued by Shanghai Contract Credit Promotion Association.
From June 5, 2004 to February, 2004, the quality management system of biochemical reagent production in Rong Sheng passed the examination and acceptance of the quality management system of medical device manufacturing enterprises of American Food and Drug Administration, and obtained the quality system audit report of medical device manufacturing enterprises.
In August 2005, the packaging specifications of hepatitis C increased by 48 persons and 576 persons, and the product was upgraded to one-year validity period.
From June 5438 to October 2005 10, the number of HIV patients increased by 48 and 576, respectively, valid for one year. 48 copies of HCV and 576 copies of HBV were officially put into production. In the national winter conscription, nearly 20 provinces used 96 copies of HIV as a physical examination reagent. The registration certificate of biochemical products has completed the transition from trial production to quasi-production, and the number of medical device registration certificates has reached 54.
In February, 2006, the patent of "Enzyme-labeled Plate with Adsorption Force" was approved with the patent number ZL 2004 2 0 1 1449.0.
In April 2006, HAV-IgM and HBcAb-IgM diagnostic kits (enzyme-linked immunosorbent assay) were added with 96 specifications and valid for one year. The original "trial" production registered products have become quasi-production registered products. Hepatitis B virus surface antibody, surface antigen diagnostic kit and syphilis toluidine red unheated serum test diagnostic kit won the certificate of "2005 Excellent Product" in Shanghai pharmaceutical industry.
In August, 2006, the reagents and methods for enzymatic determination of serum potassium and sodium ions passed the examination of China National Intellectual Property Administration (application numbers 200610028451and 2006 100284526). Rong Sheng Company was awarded the 2004-2005 certificate of honoring contracts and keeping promises by Shanghai Administration for Industry and Commerce, and the 2004-2005 AAA contract credit rating certificate by Shanghai Contract Credit Promotion Association.
From June 2006 to October 2006 10, "Rong Sheng" brand in vitro diagnostic reagent was recommended as "Brand Product of 2006" by Shanghai SME Brand Building Promotion Committee.
In 2007 10, the HIV antibody diagnostic kit won the second place in the national quality appraisal in 2006.
In July, 2007, Rong Sheng New Bio-base was built: a garden-style factory with an area of 50 mu and a building area of 35,000 square meters, a GMP workshop with a building area of 10000 square meters, a special quality control technology building and an experimental animal center.
In August 2007, Rong Sheng Company was awarded the certificate of "Integrity Unit of Labor and Social Security" by Shanghai Xuhui District Labor Association.
In June 2007, 5438+ 10 was awarded the AAA certificate of 2006 contract credit rating by Shanghai Contract Credit Promotion Association.
From June, 5438 to February, 2007, it won the certificates of "Excellent Innovative Enterprise" and "Honest Enterprise" in Shanghai biomedical industry.
065438+2008 10, Rong Sheng successfully moved and obtained the GMP certificate of the new factory. The HIV antibody diagnostic kit won the first place in the national quality evaluation in 2007.
In September 2008, the new name of "Shanghai Rong Sheng Biopharmaceutical Co., Ltd." was officially launched.
In June, 2008, 5438+ 10 was awarded the AAA certificate of contract credit rating in 2007 by Shanghai Contract Credit Promotion Association. The 2006-2007 certificate of abiding by contracts and keeping promises issued by Shanghai Administration for Industry and Commerce.
From June 2008 to October 2008 10, "Rong Sheng" brand in vitro diagnostic reagent was recommended as "Brand Product of 2008" by Shanghai SME Brand Building Promotion Committee.
On June 5438+ 10, 2009, Rong Sheng trademark was recognized as "Shanghai Famous Trademark" by Shanghai Administration for Industry and Commerce.